Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

4.0K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
4.0K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.4K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and characterization of a prototype tertiary device for proton beam stereotactic radiosurgery.

Biomedical physics & engineering express·2021
Same author

IVIg increases interleukin-11 levels, which in turn contribute to increased platelets, VWF and FVIII in mice and humans.

Clinical and experimental immunology·2021
Same author

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.

Blood advances·2020
Same author

Proton vs Hyperarcâ„¢ radiosurgery: A planning comparison.

Journal of applied clinical medical physics·2020
Same author

Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Related Experiment Video

Updated: Mar 18, 2026

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
09:35

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

15.4K

Innovating immune tolerance induction for haemophilia.

G Batsuli1, S L Meeks1, R W Herzog2

  • 1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA, USA.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|July 14, 2016
PubMed
Summary
This summary is machine-generated.

New strategies for inducing immune tolerance to factor VIII (FVIII) in haemophilia A patients show promise. Research suggests prophylactic protocols to prevent FVIII inhibitors may soon be clinically feasible.

Keywords:
factor VIIIinhibitortolerance

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Related Experiment Videos

Last Updated: Mar 18, 2026

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
09:35

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

15.4K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Area of Science:

  • Immunology
  • Hematology
  • Biotechnology

Background:

  • Haemophilia A is a genetic bleeding disorder due to Factor VIII (FVIII) deficiency.
  • FVIII inhibitors (alloantibodies) complicate treatment, increasing morbidity and costs.
  • Current inhibitor reversal protocols are lengthy, expensive, and not universally effective.

Purpose of the Study:

  • To review mechanisms of FVIII inhibitor formation.
  • To explore novel strategies for antigen-specific tolerance induction.
  • To assess the feasibility of prophylactic tolerance protocols in haemophilia A.

Main Methods:

  • Review of preclinical studies and literature on FVIII inhibitor formation.
  • Examination of immune tolerance induction strategies.
  • Focus on CD4+ T cell roles in FVIII immune responses.

Main Results:

  • CD4+ T cells are crucial in the FVIII-specific B cell response.
  • Immune tolerance can be achieved via FVIII-Fc fusion proteins delivered transplacentally.
  • Oral delivery of chloroplast-derived FVIII domains shows potential for tolerance induction.

Conclusions:

  • Antigen-specific tolerance induction is a promising prophylactic approach for haemophilia A.
  • Preclinical advancements suggest clinical feasibility of preventing FVIII inhibitors.
  • Future research may lead to effective preventative strategies for FVIII inhibitors.